Your institution may have access to this item. Find your institution then sign in to continue.
Title
Clinical trial: individualized treatment duration for hepatitis C virus genotype 1 with peginterferon-alpha 2a plus ribavirin.
Authors
Tang, K H; Herrmann, E; Pachiadakis, I; Paulon, E; Tatman, N; Zeuzem, S; Naoumov, N V
Abstract
Individualized treatment regimens, taking into account the heterogeneity of patients with chronic hepatitis C, are needed to improve treatment outcomes.